The first stop for professional medicines advice

Medicines planning

60 results

RelevanceNewest firstOldest firstTitle
Applied filters

Writing a PGD

30 July 2024

What's new in PGDs and medicines mechanisms: an update

1 May 2024

Using our annual medicines planning content: Prescribing Outlook

31 October 2023Users should be aware of the constraints and assumptions in creating our annual Prescribing Outlook publications, as well as their responsibilities for use.

Using medicines under PGD as part of a clinical trial or study

26 June 2019The below summary advises on the use of PGDs to supply or administer a medication which is part of a clinical trial, study or pilot

Using medicines at more than one location under a single PGD

16 November 2021A single PGD can be used to supply or administer medicines in more than one location. PGDs do not need to relate to specific premises.

Understanding biological and biosimilar medicines

29 June 2022Biosimilar medicines are a type of biological medicine that offer the NHS opportunities to deliver better value for certain conditions

Understanding Patient Group Directions and Integrated Care Boards

3 May 2023

The licence and supporting evidence for ustekinumab biosimilars

2 August 2024

The licence and supporting evidence for tocilizumab biosimilar

5 March 2024

The licence and supporting evidence for ranibizumab biosimilars

29 June 2022A licensed ranibizumab biosimilar is available from Teva: Ongavia. Learn about the licensed indications and supporting evidence.